This content is restricted to members.
To view our premium content, sign up for a membership:
« Back to Research Deepdives
‹ Back to Research Deepdives
Plant Stanols and Cardiovascular Risk, Beyond Intestinal Cholesterol Absorption
References
1. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72.
2. Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: A Mendelian randomization analysis. J Am Coll Cardiol. 2013;9(1):90–8.
3. Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, et al. Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol. JAMA. 2017;6(7):1–17.
4. Burgess S, Freitag DF, Khan H, Gorman DN, Thompson SG. Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions. PLoS One. 2014;9(10):e108891.
5. Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;1–28.
6. Goldstein JL, Brown MS. Genes to Statins. Cell. 2015;161(1):161–72.
7. Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis. JAMA. 2016;316(12):1289–97.
8. Smet E De, Mensink RP, Plat J. Effects of plant sterols and stanols on intestinal cholesterol metabolism: Suggested mechanisms from past to present. Mol Nutr Food Res. 2012 Jul;56(7):1058–72.
9. Musa-Veloso K, Poon TH, Elliot JA, Chung C. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins Leukot Essent Fatty Acids. 2011 Jul;85(1):9–28.
10. Gylling H, Halonen J, Lindholm H, Konttinen J, Simonen P, Nissinen MJ, et al. The effects of plant stanol ester consumption on arterial stiffness and endothelial function in adults: a randomised controlled clinical trial. BMC Cardiovasc Disord. 2013 Dec 10;13(1):50.
11. Ostlund RE. Phytosterols and cholesterol metabolism. Curr Opin Lipidol. 2004 Feb;15(1):37–41.
12. Ostlund RE, Racette SB, Stenson WF. Effects of Trace Components of Dietary Fat on Cholesterol Metabolism: Phytosterols, Oxysterols, and Squalene. Nutr Rev. 2002 Nov 1;60(11):349–59.
13. Ruuth M, Nguyen SD, Vihervaara T, Hilvo M, Laajala TD, Kondadi PK, et al. Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths. Eur Heart J. 2018 Jul 14;39(27):2562–73.
14. Ruuth M, Janssen LGM, Äikäs L, Tigistu-Sahle F, Nahon KJ, Ritvos O, et al. LDL aggregation susceptibility is higher in healthy South Asian compared with white Caucasian men. J Clin Lipidol. 2019 Nov;13(6):910-919.e2.
15. Simonen PP, Gylling H, Miettinen TA. Body Weight Modulates Cholesterol Metabolism in Non‐Insulin Dependent Type 2 Diabetics. Obes Res. 2002 May 6;10(5):328–35.